1. 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. Issue 1 (14th March 2018) Authors: van der Heijde, Désirée; Deodhar, Atul; FitzGerald, Oliver; Fleischmann, Roy; Gladman, Dafna; Gottlieb, Alice B; Hoepken, Bengt; Bauer, Lars; Irvin-Sellers, Oscar; Khraishi, Majed; Peterson, Luke; Turkiewicz, Anthony; Wollenhaupt, Jürgen; Mease, Philip J Journal: RMD open Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis. Issue 7 (28th May 2019) Authors: Deodhar, Atul; Gensler, Lianne S.; Kay, Jonathan; Maksymowych, Walter P.; Haroon, Nigil; Landewé, Robert; Rudwaleit, Martin; Hall, Stephen; Bauer, Lars; Hoepken, Bengt; de Peyrecave, Natasha; Kilgallen, Brian; van der Heijde, Désirée Journal: Arthritis & rheumatology Issue: Volume 71:Issue 7(2019) Page Start: 1101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease–Associated Chronic Pain. (31st December 2015) Authors: Rascol, Olivier; Zesiewicz, Theresa; Chaudhuri, K. Ray; Asgharnejad, Mahnaz; Surmann, Erwin; Dohin, Elisabeth; Nilius, Sigrid; Bauer, Lars Journal: Journal of clinical pharmacology Issue: Volume 56:Number 7(2016) Page Start: 852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0742 ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETS. (June 2019) Authors: Coates, Laura C.; Merola, Joseph F.; Fitzgerald, Oliver; Kavanaugh, Arthur; Gottlieb, Alice B.; Tillett, William; Bauer, Lars; Hoepken, Bengt; Nurminen, Tommi; Mease, Philip J.; Helliwell, Philip; Heijde, Désirée van der Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Certolizumab Pegol Efficacy in Patients With Non‐Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C‐Reactive Protein Status: An Analysis From the C‐axSpAnd Study. Issue 9 (22nd June 2022) Authors: Robinson, Philip C.; Maksymowych, Walter P.; Gensler, Lianne S.; Hall, Stephen; Rudwaleit, Martin; Hoepken, Bengt; Bauer, Lars; Kumke, Thomas; Kim, Mindy; de Peyrecave, Natasha; Deodhar, Atul Journal: ACR open rheumatology Issue: Volume 4:Issue 9(2022) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations. (December 2013) Authors: Elshoff, Jan-Peer; Timmermann, Lars; Schmid, Miriam; Arth, Christoph; Komenda, Michael; Brunnert, Marcus; Bauer, Lars Journal: Current medical research and opinion Issue: Volume 29:Number 12(2013:Dec.) Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to "Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study" [Park. Relat. Disord. 28 (2016) 49–55]. (May 2017) Authors: Zhang, Zhen-Xin; Shang, Hui-Fang; Hu, Xingyue; Chen, Shengdi; Zhao, Zhongxin; Du, Xinlu; Surmann, Erwin; Bauer, Lars; Asgharnejad, Mahnaz Journal: Parkinsonism & related disorders Issue: Volume 38(2017) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe. (25th June 2020) Authors: Baraliakos, Xenofon; Witte, Torsten; De Clerck, Luc; Frediani, Bruno; Collantes-Estévez, Eduardo; Katsifis, Gkikas; VanLunen, Brenda; Kleine, Elisabeth; Hoepken, Bengt; Bauer, Lars; Goodson, Nicola Journal: Rheumatology Issue: Volume 60:Number 1(2021) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease. Issue 1 (December 2016) Authors: Hauser, Robert; Slawek, Jaroslaw; Barone, Paolo; Dohin, Elisabeth; Surmann, Erwin; Asgharnejad, Mahnaz; Bauer, Lars Journal: BMC neurology Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease. (23rd July 2016) Authors: Chung, Sun Ju; Asgharnejad, Mahnaz; Bauer, Lars; Ramirez, Francisco; Jeon, Beomseok Journal: Expert opinion on pharmacotherapy Issue: Volume 17:Number 11(2016) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗